Filing Details
- Accession Number:
- 0000903423-15-000581
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-07 16:31:39
- Reporting Period:
- 2015-10-07
- Filing Date:
- 2015-10-07
- Accepted Time:
- 2015-10-07 16:31:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1583107 | Theravance Biopharma Inc. | TBPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1131399 | Plc Glaxosmithkline | 980 Great West Road Brentford, Middlesex, X0 TW8 9GS | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2015-10-07 | 44,574 | $607,543.62 | 8,343,792 | No | 4 | P | Indirect | By Corporation |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Corporation |
Footnotes
- Ordinary shares purchased pursuant to the right of Glaxo Group Limited ("GGL"), an indirect wholly owned subsidiary of the Reporting Person, under Section 2.1(d)(ii) of the Governance Agreement by and among Theravance Biopharma, Inc. (the "Issuer") and GGL, dated as of March 3, 2014. Pursuant to Section 2.1(d)(ii), GGL has the right to purchase from the Issuer, on a quarterly basis, sufficient ordinary shares to maintain its ownership percentage in the Issuer taking into account the preceding quarter's option exercise and equity vesting activity.
- Ordinary Shares are held of record by GGL, an indirect wholly owned subsidiary of the Reporting Person.
Billionaire Hedge Funds
